2024 Global Pharma Outlook Looks Challenging For Pharma Cos

A recent study suggests that economic pressures, market expectations and also global regulations are all going to pose a serious challenge for Pharma in 2024.

500 Drugs Set To Witness A Price Hike In The US In Jan 2024

As per data analysed by 3 Axis Advisors, a healthcare research firm, major drugmakers would be raising prices on more than 500 drugs in US this January 2024.

US Federal & State Drug Pricing Posing Major Challenges

The policy and regulatory environment across the US drug pricing landscape will continue to remain hostile because of the execution & evolution of the IRA.

M&A Revival In The Biopharmaceutical Sector Back On Track

2023 second half saw revival of M&A in biopharmaceutical sector due to patent expiration, pipeline diversity, and availability of liquid funds with big pharma.

Global Advanced Empty Capsule Sector To Grow 7.4% Till 2033

Global advanced empty capsules are expected to be US$ 905.6mn in 2023 and hit CAGR of 7.4% till 2033 due to chronic illness prevalence & aging population.